Capecitabine-docetaxel combination treatment
Julia Mandelblat1, Tayyaba Bashir, Daniel R Budman
1New York University, Don Monti Division of Oncology, North Shore University Hospital, Manhasset, New York, USA.
Expert Review of Anticancer Therapy
|October 6, 2006
Summary
Combination chemotherapy for metastatic breast cancer shows promise, with docetaxel and capecitabine demonstrating survival benefits. Further research is needed to define optimal use in specific patient subgroups.
Area of Science:
- Medical Oncology
- Clinical Pharmacology
Background:
- Metastatic breast cancer (MBC) affects about 50% of breast cancer patients.
- Optimal MBC treatment remains undefined due to patient heterogeneity and varied agents.
- Sequential single-agent therapy is common, with uncertainty regarding combination therapy benefits and toxicity.
Purpose of the Study:
- To evaluate the efficacy of combination chemotherapy in metastatic breast cancer.
- To compare combination therapy with sequential single-agent treatment.
- To identify potential subgroups that may benefit from combination regimens.
Main Methods:
- Review of existing preclinical and clinical trials on combination cytotoxic therapies.
- Analysis of studies comparing docetaxel plus capecitabine with paclitaxel plus gemcitabine.
- Assessment of survival benefits and response rates in MBC patients.
Main Results:
- Docetaxel and capecitabine combination demonstrated increased time to tumor progression and overall survival.
- Paclitaxel plus gemcitabine showed similar response rates and survival benefits compared to docetaxel plus capecitabine.
- Uncertainty remains regarding combination therapy advantages for all MBC patients or specific subgroups.
Conclusions:
- Combination chemotherapy, particularly docetaxel with capecitabine, offers survival benefits in MBC.
- Combination therapy may be advantageous for patients needing rapid tumor burden reduction.
- Further research is needed to define optimal combination strategies and identify specific patient subgroups for these treatments.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...